ripekg:evaluation/RIPEA82B663F650C41F5F |
prov:used |
ripekg:study-design-evidence/RIPEA82B663F650C41F5F |
ripekg:study-design-evidence/RIPEA82B663F650C41F5F |
rdf:type |
rdfs:Resource |
ripekg:study-design-evidence/RIPEA82B663F650C41F5F |
rdf:type |
owl:Thing |
ripekg:study-design-evidence/RIPEA82B663F650C41F5F |
rdf:type |
ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence |
ripekg:study-design-evidence/RIPEA82B663F650C41F5F |
rdf:type |
ripe:StudyDesignEvidenceStudy design evidence |
ripekg:study-design-evidence/RIPEA82B663F650C41F5F |
rdf:type |
tido:Evidence |
ripekg:study-design-evidence/RIPEA82B663F650C41F5F |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA82B663F650C41F5F |
ripekg:study-design-evidence/RIPEA82B663F650C41F5F |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA82B663F650C41F5F |
ripekg:study-design-evidence/RIPEA82B663F650C41F5F |
ripe:concerns |
ripekg:work/10.1186%2Fs13063-025-08916-5Therapeutic effects of curcumin and piperine combination in critically ill patients with sepsis: a randomized double-blind controlled trial |
ripekg:study-design-evidence/RIPEA82B663F650C41F5F |
ripe:recruitmentEndDateExtractionRationale |
No direct LPI; range end is not used for recruitment_finish. |
ripekg:study-design-evidence/RIPEA82B663F650C41F5F |
ripe:recruitmentStartDate |
02-2021 |
ripekg:study-design-evidence/RIPEA82B663F650C41F5F |
ripe:recruitmentStartDateExtractionRationale |
The study was conducted from Feb 2021 to May 2022; used start of conducted range as recruitment_start per rule 5; no specific FPI elsewhere. |
ripekg:study-design-evidence/RIPEA82B663F650C41F5F |
ripe:studyEndDate |
05-2022 |
ripekg:study-design-evidence/RIPEA82B663F650C41F5F |
ripe:studyEndDateExtractionRationale |
The study was conducted from Feb 2021 to May 2022; used end of conducted range as study_end_date per rule 5; no specific completion date. |
ripekg:study-design-evidence/RIPEA82B663F650C41F5F |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA82B663F650C41F5F-human-2-2 |
ripekg:study-design-evidence/RIPEA82B663F650C41F5F |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA82B663F650C41F5F-inspectai-2-2 |